2576 — Zhejiang Taimei Medical Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$2.71bn
- HK$1.48bn
- CNY512.54m
Annual cashflow statement for Zhejiang Taimei Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -480 | -423 | -356 | -217 | -50.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 155 | 41 | -25.8 | 93.3 | -9.22 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 71.1 | -3.21 | -21 | -117 | 0.562 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -218 | -329 | -351 | -202 | -39.4 |
| Capital Expenditures | -32.4 | -28.2 | -9.48 | -5.68 | -3.77 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -347 | 22.3 | 247 | -278 | 333 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -379 | -5.88 | 238 | -284 | 329 |
| Financing Cash Flow Items | -7.72 | 320 | -8.5 | -5.31 | -0.837 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -40.1 | 286 | -39.3 | 281 | 24.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -645 | -12.6 | -149 | -199 | 306 |